441 related articles for article (PubMed ID: 30894464)
21. IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.
Ahi YS; Yimer D; Shi G; Majdoul S; Rahman K; Rein A; Compton AA
mBio; 2020 Jan; 11(1):. PubMed ID: 31964738
[TBL] [Abstract][Full Text] [Related]
22. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
[TBL] [Abstract][Full Text] [Related]
23. Intact Viral Particle Counts Measured by Flow Virometry Provide Insight into the Infectivity and Genome Packaging Efficiency of Moloney Murine Leukemia Virus.
Renner TM; Tang VA; Burger D; Langlois MA
J Virol; 2020 Jan; 94(2):. PubMed ID: 31694951
[TBL] [Abstract][Full Text] [Related]
24. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
Freed EO; Martin MA
J Virol; 1996 Jan; 70(1):341-51. PubMed ID: 8523546
[TBL] [Abstract][Full Text] [Related]
25. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
[TBL] [Abstract][Full Text] [Related]
26. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail.
Wyma DJ; Jiang J; Shi J; Zhou J; Lineberger JE; Miller MD; Aiken C
J Virol; 2004 Apr; 78(7):3429-35. PubMed ID: 15016865
[TBL] [Abstract][Full Text] [Related]
27. Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.
Logg CR; Baranick BT; Lemp NA; Kasahara N
J Mol Biol; 2007 Jun; 369(5):1214-29. PubMed ID: 17498744
[TBL] [Abstract][Full Text] [Related]
28. Characterization of producer cell-dependent restriction of murine leukemia virus replication.
Serhan F; Jourdan N; Saleun S; Moullier P; Duisit G
J Virol; 2002 Jul; 76(13):6609-17. PubMed ID: 12050374
[TBL] [Abstract][Full Text] [Related]
29. Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles.
Merten CA; Stitz J; Braun G; Poeschla EM; Cichutek K; Buchholz CJ
J Virol; 2005 Jan; 79(2):834-40. PubMed ID: 15613311
[TBL] [Abstract][Full Text] [Related]
30. A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type- and Rab11-FIP1C-dependent incorporation into virions.
Qi M; Chu H; Chen X; Choi J; Wen X; Hammonds J; Ding L; Hunter E; Spearman P
Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7575-80. PubMed ID: 26034275
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms for Env glycoprotein acquisition by retroviruses.
Johnson MC
AIDS Res Hum Retroviruses; 2011 Mar; 27(3):239-47. PubMed ID: 21247353
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of infectious murine leukemia virus production by Fv-4 env gene products exerting dominant negative effect on viral envelope glycoprotein.
Takeda A; Matano T
Microbes Infect; 2007; 9(14-15):1590-6. PubMed ID: 18023391
[TBL] [Abstract][Full Text] [Related]
33. Inter-retroviral fusion mediated by human immunodeficiency virus or murine leukemia virus glycoproteins: independence of cellular membranes and membrane vesicles.
Sparacio S; Pfeiffer T; Holtkotte D; Bosch V
Virology; 2002 Mar; 294(2):305-11. PubMed ID: 12009872
[TBL] [Abstract][Full Text] [Related]
34. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS
Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556
[TBL] [Abstract][Full Text] [Related]
35. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
[TBL] [Abstract][Full Text] [Related]
36. TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions.
Denesvre C; Carrington C; Corbin A; Takeuchi Y; Cosset FL; Schulz T; Sitbon M; Sonigo P
J Virol; 1996 Jul; 70(7):4380-6. PubMed ID: 8676461
[TBL] [Abstract][Full Text] [Related]
37. Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release.
Noble B; Abada P; Nunez-Iglesias J; Cannon PM
J Virol; 2006 Mar; 80(6):2924-32. PubMed ID: 16501101
[TBL] [Abstract][Full Text] [Related]
38. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
Kiernan RE; Freed EO
J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
[TBL] [Abstract][Full Text] [Related]
39. TR1.3 viral pathogenesis and syncytium formation are linked to Env-Gag cooperation.
Murphy SL; Gaulton GN
J Virol; 2007 Oct; 81(19):10777-85. PubMed ID: 17634219
[TBL] [Abstract][Full Text] [Related]
40. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.
Lambelé M; Labrosse B; Roch E; Moreau A; Verrier B; Barin F; Roingeard P; Mammano F; Brand D
J Virol; 2007 Jan; 81(1):125-40. PubMed ID: 17050592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
